SB202190
To Order Contact us: lieven@wlsolutions.be
SB202190 |
||
MBS808173-5x5mg | 5x5mg | EUR 745 |
SB202190 (FHPI) |
||
A1632-100 | 100 mg | EUR 80 |
Description: P38 MAPK inhibitor |
SB202190 (FHPI) |
||
A1632-5.1 | 10 mM (in 1mL DMSO) | EUR 44 |
Description: P38 MAPK inhibitor |
SB202190 (FHPI) |
||
MBS575414-100mg | 100mg | EUR 175 |
SB202190 (FHPI) |
||
MBS575414-10mg | 10mg | EUR 135 |
SB202190 (FHPI) |
||
MBS575414-200mg | 200mg | EUR 225 |
SB202190 (FHPI) |
||
MBS575414-25mg | 25mg | EUR 140 |
SB202190 (FHPI) |
||
MBS575414-50mg | 50mg | EUR 145 |
SB202190 (FHPI, 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole) |
||
MBS6023840-1mg | 1(mg | EUR 345 |
SB202190 (FHPI, 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole) |
||
MBS6023840-25mg | 25mg | EUR 400 |
SB202190 (FHPI, 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole) |
||
MBS6023840-5mg | 5(mg | EUR 475 |
SB202190 (FHPI, 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole) |
||
MBS6023840-5x5mg | 5x5mg | EUR 1990 |
SB-7720770 2HCl |
||
562446 | 5.0mg | EUR 400 |
SB4315242, Free Base [CAS# 301836-41-9] |
||
S-7800 | 5 mg | EUR 48 |
SB-366791 |
||
20-abx076632 |
|
|
SB216763 |
||
20-abx076766 |
|
|
SB431542 |
||
20-abx076786 |
|
|
SB203580 |
||
20-abx076800 |
|
|
SB-265610 |
||
526278 | 10.0mg | EUR 250 |
SB-222200 |
||
526724 | 50.0mg | EUR 450 |
SB-408124 |
||
526763 | 5.0mg | EUR 150 |
SB649868 |
||
526934 | 100.0mg | EUR 1550 |
SB-756050 |
||
528518 | 100.0mg | EUR 350 |
SB328437 |
||
532664 | 10.0mg | EUR 325 |
SB452533 |
||
532670 | 10.0mg | EUR 345 |
SB-742457 |
||
9568-25 | each | EUR 652.8 |